Prakash Singh Shekhawat

Dedicated and patient-centric medical professional with over 10 years of clinical experience in hematology, recognized for strong communication skills that engage individuals from diverse backgrounds. An exceptional clinical eye for early diagnosis ensures timely and accurate patient care, while a commitment to enhancing healthcare delivery drives the introduction of efficient systems and processes that streamline operations and improve patient outcomes. Proven track record of fostering positive relationships with patients and colleagues contributes to a collaborative and supportive healthcare environment. Authored over 100 publications in national and international journals, showcasing a commitment to advancing medical knowledge and practice.

• I was involved in FACT accreditation of the BMT unit of Tata Medical Centre Kolkata (Only FACT centre in India) under the leadership of Dr Mammen Chandy and Dr Vivek Radhakrishnan.
• Responsible for implementing Indian Childhood Collaborative Leukemia (ICICLe) group programme at NRS medical college and got an ICMR grant of Rs. 1Cr.

• Prof Mammen, Chandy, Director, Tata Medical Centre, Kolkata, Kolkata
• Prof Reena, Nair, Senior consultant, Tata Medical Centre, Kolkata, Kolkata
• Dr Saurabh, Bhave, Senior consultant, Tata Medical Centre, Kolkata, Kolkata
• Prof T K, Dolai, Professor and Head, Department of Hematology, NRS Medical College, Kolkata, Kolkata
• Dr Anupam, Chakrapani, Director Hematology & BMT, Apollo Kolkata, Kolkata
• Dr Ajay, Bapna, Director & HOD, Medical Oncology, BMCHRC, Jaipur, Jaipur

• ACHAPTER CONTRIBUTION IN BOOK-
• Chapter in Medicine API 2021 book titled “ Approach to a case of polycythemia- More blood may be bad...”
• Chapter in API textbook of medicine on Nutritional Anemia, April 2022
• Chapter in API Medicine Update on “Revisiting pancytopenia”- May 2023
• Chapter on High grade NHL in ICH-IAP Hematology Monograph 2024
• Guideline for management of anemia in elderly- ICH and ISBMT joint book
• B -PAPER PUBLICATION
• Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN. COVID-19 mechanisms in the human body—What we know so far. Frontiers in immunology. 2021 Nov 1;12:693938.
• Kumar A, Narayan RK, Kulandhasamy M, Prasoon P, Kumari C, Kumar S, Pareek V, Sesham K, Shekhawat PS, Kant K, Kumar S. COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes. Expert Reviews in Molecular Medicine. 2021 Jan;23:e7.
• Kumar A, Prasoon P, Sekhawat PS, Pareek V, Faiq MA, Kumari C, Narayan RK, Kulandhasamy M, Kant K. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective. International Reviews of Immunology. 2021 Mar 4;40(1-2):54-71.
• Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN. Mecanismos del COVID-19 en el cuerpo humano: Lo que sabemos hasta ahora. Kompass Neumología. 2022 Apr 28;4(1):3-20.
• Kar R, Dolai TK, Shekhawat PS, Malhotra P, Singh A, Naithani R, Mandal PK, Ganesan P, Manivannan P, Basu D, Srivastava A. Indian society of hematology and blood transfusion (ISHBT) consensus document on hematological practice during COVID-19 pandemic. Indian Journal of Hematology and Blood Transfusion. 2021 Jan;37:1-9.
• Baveja A, Mandal PK, Chattopadhyay A, Garg M, Shekhawat PS, Dolai TK. Profile of autoimmune haemolytic anaemia: analysis of 10 years data from a hematology center in eastern India. Asian Hematology Research Journal. 2021;4(3):33-43.
• Kumar A, Sesham K, Narayan RK, Prasoon P, Kumari C, Kumar S, Kumar S, Pareek V, Shekhawat PS, Kant K, Kulandhasamy M. Host Vulnerability Factors Affecting Patient Outcomes in COVID-19: An Update. Available at SSRN 3769784. 2021.
• Podder D, Bhave SJ, Shekhawat PS, Nair R. Clinicopathological characteristics and outcome in patients of primary CNS lymphoma treated with modified de-angelis protocol: an audit. Clinical Lymphoma Myeloma and Leukemia. 2018 Sep 1;18:S279-80.
• Mandal PK, Shekhawat PS. Telemedicine in hematology;long-term implications of a short-term experience during COVID-19 pandemic. J Hematol Allied Sci 2021;1:54-8
• Shekhawat PS, Garg M, Dolai TK. Bone infarct (osteonecrosis) as late side effect of steroid in acute lymphoblastic leukemia survivor. Journal of Hematology and Allied Sciences. 2021 May 31;1(1):38-40.
• Baveja A, Mandal PK, Garg M, Shekhawat PS, Mitra S, Chattopadhyay A, Bhattacharya S, Baul SN, De R, Dolai TK. Myeloid sarcoma: experience from a hematology care centre of Eastern India. Journal of Hematology and Allied Sciences. 2021 May 31;1(1):33-7.
• Shekhawat PS, Mandal PK, Garg M, Baveja A, Dolai TK. Acute Promyelocytic Leukemia: A Decade Long Experience with Evolving Treatment Strategies. Asian Hematology Research Journal. 2021 May 13;4(3):24-32.
• Shekhawat PS, Mandal PK, Garg M, Dolai TK. Azacitidine Causing Generalised Skin Rash: A Rare Side Effect. Available at SSRN 3627535. 2020 Jul 14.
• TKD Prakas K Mandal, Prakash S. Shekhawat.CARE IN CRISIS: MANAGEMENT OF HEMATOLOGY PATIENTS DURING COVID 19 PANDEMIC wjpmr 6 (9), 95-101
• PK M, Karthika V, Bhowmik A, Baul S, Dutta B, Sen A, Jain M, Shekhawat PS, Baveja A, Garg M, De R. Institutional Sensitivity Pattern Guides Initial Antimicro-bial Selection in Febrile Neutropenia; Sharing Experience from a Hemato-Oncology Care Center in India.
• Malini Garg, Prakas K. Mandal, Prakash S. Shekhawat, Tuphan K. Dolai. Hemarthrosis in hemoglobin E beta thalassemia: a rare clinical scenario. ijmedicine 1582-1584 DOI: 10.18203/2349-3933.ijam20204077
• C POSTER PRESENTATIONS IN VARIOUS CONFERENCES:
• HOPE ASIA 2019
• Status Of Hb E-Beta Thalassemia in A Tertiary Centre In Eastern India-HOPE
• Hematocon 2019
• Real world scenario of Bortezomib-Thalidomide-Dexamethasone(vtd) in newly diagnosed Multiple Myeloma
• APML Management in a resource limited setting: Real world scenario
• Beshcon 2020
• Sepsis: Real killer in Real world
• Hematocon 2020
• Experience of BFM 2002 protocol in Acute Lymphoblastic Leukaemia: Single Centre Experience
• Management of acute promyelocytic leukaemia (APML) in a resource limited setting
• Hematocon 2022
• At various state level conferences
• D. Reviewer: of Journal of hematology and allied sciences

NEJM, BJH, Blood, AJH,TLH etc